Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial

Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes

(2011) Emilie Capel et al.   ANTIVIRAL THERAPY

Assessing Adiposity

(2011) Marc-Andre Cornier et al.   CIRCULATION

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

(2011) Grace A. McComsey et al.   JOURNAL OF INFECTIOUS DISEASES

Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey

(2011) Hélène C.F. Côté et al.   MITOCHONDRION

Improvement in Vitamin D Deficiency Following Antiretroviral Regime Change: Results from the MONET Trial

(2010) Julie Fox et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

(2010) Hans‐Jürgen Stellbrink et al.   CLINICAL INFECTIOUS DISEASES

HIV and the body: a review of multidisciplinary management

(2010) J Rockstroh et al.   HIV MEDICINE

Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

(2010) Jeffrey L Lennox et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial

(2010) J.-L. Meynard et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

(2009) Richard H Haubrich et al.   AIDS

Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects

(2009) Giovanni Guaraldi et al.   ATHEROSCLEROSIS

Simplification of Antiretroviral Therapy with Tenofovir‐Emtricitabine or Abacavir‐Lamivudine: A Randomized, 96‐Week Trial

(2009) Allison Martin et al.   CLINICAL INFECTIOUS DISEASES

A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression

(2009) Esteban Martínez et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Severity of Lipodystrophy Is Associated with Decreased Health-Related Quality of Life

(2008) Giovanni Guaraldi et al.   AIDS PATIENT CARE AND STDS

Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk Factors

(2008) Carl Grunfeld et al.   CIRCULATION

A 96‐Week Comparison of Lopinavir‐Ritonavir Combination Therapy Followed by Lopinavir‐Ritonavir Monotherapy versus Efavirenz Combination Therapy

(2008) D. William Cameron et al.   JOURNAL OF INFECTIOUS DISEASES

General and Abdominal Adiposity and Risk of Death in Europe

(2008) T. Pischon et al.   NEW ENGLAND JOURNAL OF MEDICINE